USPTO serial 88184087
VELEXBRU
Reviewed by CopyMark Law Group
Reg. 5860599Status 710
- Filing date
- Status date
- Registration date
- Sep 17, 2019
- Examiner
- VERHOSEK, WILLIAM T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VELEXBRU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CARRIGTOHILL, CO. CORK, IE
Carrigtohill Co. Cork,, IE
CARRIGTOHILL, CO. CORK, IE
CHUO-KU, OSAKA-SHI, OSAKA 541-8526, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gretchen R. Stroud
333 Lakeside DriveFoster City, CA 94404UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gilead Sciences Ireland UC
- Other trademarks owned by Gilead Sciences Ireland UC
- Other trademarks owned by Gilead Sciences Ireland UC
- Other trademarks owned by ONO PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named VELEXBRU
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 17, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 19, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 11, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 11, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 11, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 11, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 11, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 17, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 2, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 12, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 28, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 23, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2019 | ALIE | ASSIGNED TO LIE | — |
| May 17, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 12, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 12, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 11, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2018 | NWAP | NEW APPLICATION ENTERED | — |